Trials / Sponsors / AVM Biotechnology Inc
AVM Biotechnology Inc
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS ARDS, Covid19, Influenza, Human | Phase 1 | 2026-12-01 |
| Recruiting | The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies Lymphoid Malignancies | Phase 1 / Phase 2 | 2020-11-06 |
| Available | Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma | — | — |